Identifying Non-Bisphosphonate Inhibitors of Isoprenoid Biosynthesis
Author Information
Author(s): Jacob D Durrant, Rong Cao, Alemayehu A Gorfe, Wei Zhu, Jikun Li, Anna Sankovsky, Eric Oldfield, J Andrew McCammon
Primary Institution: University of California San Diego
Hypothesis
Can we identify novel non-bisphosphonate inhibitors of farnesyl diphosphate synthase and undecaprenyl diphosphate synthase using computer-aided drug design?
Conclusion
The study successfully identified several low-micromolar inhibitors of farnesyl diphosphate synthase and undecaprenyl diphosphate synthase, suggesting a new approach to drug development.
Supporting Evidence
- Identified compounds inhibit both farnesyl diphosphate synthase and undecaprenyl diphosphate synthase.
- These inhibitors are less likely to be removed from the body quickly compared to bisphosphonates.
- Compound 5 shows activity against both FPPS and UPPS, indicating potential for dual-target drugs.
Takeaway
Researchers used computer programs to find new drugs that can stop bacteria from growing by blocking important processes in their cells.
Methodology
The study employed a virtual-screening approach combined with molecular dynamics simulations to identify inhibitors.
Limitations
The activity of the identified compounds needs further optimization to improve their effectiveness compared to existing drugs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website